Key Drug Research & Evidence Sources

Key drug research and evidence sources play a critical role in effectively addressing substance prevalence. Below are leading national, regional, and global research organisations from Australasia, Europe, North America, and international academic platforms that produce high‑quality evidence across population‑level surveillance, clinical assessment, policy and programme evaluation, and emerging trends. Together, these sources support law enforcement, practitioners, researchers, and decision‑makers in accessing trusted research, guidelines, and data spanning multiple substances, settings, and populations

Filter by Country

Filter by Region

Australasia Research Sources

National Drug and Alcohol Research Centre
Accessible data	Settings	Primary Substances
Population-level substance use identification Monitoring treatment outcomes Clinical assessment and treatment planning	Research and epidemiological studies Clinical and specialist treatment services	Multi-substance use Alcohol Opioids Stimulants

National Drug Research Institute
Accessible data	Settings	Primary Substances
Policy and programme monitoring Population-level substance use identification Early detection and brief intervention	Research and epidemiological studies Community services Policy and programme monitoring	Multi-substance use Alcohol Cannabis

Canada Research Sources

Canadian Centre on Substance Use and Addiction (Research Library)
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Policy and programme monitoring Population-level substance use identification	Research and epidemiological studies Policy and programme monitoring	Multi-substance use Opioids Cannabis

Canadian Institutes of Health Research
Accessible data	Settings	Primary Substances
Monitoring treatment outcomes Clinical assessment and treatment planning Population-level substance use identification	Research and epidemiological studies Clinical and specialist treatment services	Multi-substance use

Europe Research Sources

European Union Drugs Agency (Publications & Best Practice Portal)
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Monitoring treatment outcomes Early warning and trend monitoring	Research and epidemiological studies Clinical and specialist treatment services Policy and programme monitoring	Multi-substance use Emerging psychoactive substances Stimulants

Global Academic

Cochrane
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Monitoring treatment outcomes	Research and epidemiological studies Clinical and specialist treatment services	Multi-substance use

PubMed
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Population-level substance use identification	Research and epidemiological studies	Multi-substance use

Google Scholar
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Policy and programme monitoring	Research and epidemiological studies	Multi-substance use

Scopus
Accessible data	Settings	Primary Substances
Monitoring treatment outcomes Clinical assessment and treatment planning	Research and epidemiological studies	Cross-substance / Methodology

Web of Science
Accessible data	Settings	Primary Substances
Monitoring treatment outcomes Clinical assessment and treatment planning	Research and epidemiological studies	Cross-substance / Methodology

Global Research Sources

Campbell Collaboration
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Policy and programme monitoring	Research and epidemiological studies Criminal justice settings	Multi-substance use

Institute for Health Metrics and Evaluation
Accessible data	Settings	Primary Substances
Population-level substance use identification Monitoring treatment outcomes	Research and epidemiological studies National surveillance systems	Multi-substance use

EQUATOR Network
Accessible data	Settings	Primary Substances
Monitoring treatment outcomes Clinical assessment and treatment planning	Research and epidemiological studies	Cross-substance / Methodology

United Kingdom Research Sources

National Institute for Health and Care Excellence
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Monitoring treatment outcomes Mental health and co-occurring condition screening	Clinical and specialist treatment services Policy and programme monitoring Research and epidemiological studies	Multi-substance use Alcohol Opioids

National Institute for Health and Care Research
Accessible data	Settings	Primary Substances
Monitoring treatment outcomes Clinical assessment and treatment planning Population-level substance use identification	Research and epidemiological studies Clinical and specialist treatment services	Multi-substance use

United States Research Sources

National Institute on Drug Abuse
Accessible data	Settings	Primary Substances
Population-level substance use identification Clinical assessment and treatment planning Monitoring treatment outcomes	Research and epidemiological studies National surveillance systems	Multi-substance use Opioids Cannabis Stimulants

Substance Abuse and Mental Health Services Administration (Evidence-Based Practices Resource Center)
Accessible data	Settings	Primary Substances
Clinical assessment and treatment planning Monitoring treatment outcomes Mental health and co-occurring condition screening	Clinical and specialist treatment services Policy and programme monitoring	Multi-substance use

Centers for Disease Control and Prevention (Research & Publications)
Accessible data	Settings	Primary Substances
Population-level substance use identification Monitoring treatment outcomes HIV and substance-related behavioural risk	Research and epidemiological studies National surveillance systems	Multi-substance use Opioids Injection-related risk behaviours